HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 282, Issue 16, 11715-11721, April 20, 2007

This Article Full Text Full Text (PDF) All Versions of this Article: 282/16/11715    most recent M701085200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mulherkar, N. Articles by Prabhakar, B. S. Search for Related Content PubMed PubMed Citation Articles by Mulherkar, N. Articles by Prabhakar, B. S. Social Bookmarking                      What's this?

MADD/DENN Splice Variant of the IG20 Gene Is a Negative Regulator of Caspase-8 Activation

KNOCKDOWN ENHANCES TRAIL-INDUCED APOPTOSIS OF CANCER CELLS^*

From the Department of Microbiology and Immunology, College of Medicine, University of Illinois, Chicago, Illinois 60612

The MADD variant of the IG20 gene is necessary and sufficient for cancer cell survival. Abrogation of MADD, but not the other IG20 splice variants, can render cancer cells more susceptible to spontaneous as well as TRAIL (tumor necrosis factor -related apoptosis-inducing ligand)-induced apoptosis. Both types of apoptosis in cells devoid of MADD can be inhibited by expression of CrmA or dominant-negative FADD, thereby suggesting that endogenous MADD may be targeting caspase-8 activation. Immunoprecipitation studies showed that MADD down-modulation could lead to caspase-8 activation at the death receptors without an apparent increase in the recruitment of death-inducing signaling complex components such as FADD. Further, we found that MADD can directly interact with death receptors, but not with either caspase-8 or FADD, and can inhibit caspase-8 activation. These results clearly demonstrate the importance of MADD in the control of cancer cell survival/death and in conferring significant resistance to TRAIL-induced apoptosis. In addition, our results indicate the therapeutic potential of MADD abrogation in enhancing TRAIL-induced selective apoptosis of cancer cells.

Received for publication, February 5, 2007 , and in revised form, February 20, 2007.

^* This work was supported by Grant 5R01CA107506 from the National Institutes of Health, Bethesda, MD. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ Current address: Inst. for Cancer Genetics, Columbia University, New York, NY 10032.

² To whom correspondence should be addressed: Rm. E-705, 835 South Wolcott Ave. (M/C 790), Chicago, IL 60612. Tel.: 312-996-4945; Fax: 312-996-6415; E-mail: bprabhak{at}uic.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B. R. V. V. S. N. Kurada, L. C. Li, N. Mulherkar, M. Subramanian, K. V. Prasad, and B. S. Prabhakar MADD, a Splice Variant of IG20, Is Indispensable for MAPK Activation and Protection against Apoptosis upon Tumor Necrosis Factor-{alpha} Treatment J. Biol. Chem., May 15, 2009; 284(20): 13533 - 13541. [Abstract] [Full Text] [PDF]

				M. Subramanian, T. Pilli, P. Bhattacharya, F. Pacini, Y. E. Nikiforov, P. V. Kanteti, and B. S. Prabhakar Knockdown of IG20 Gene Expression Renders Thyroid Cancer Cells Susceptible to Apoptosis J. Clin. Endocrinol. Metab., April 1, 2009; 94(4): 1467 - 1471. [Abstract] [Full Text] [PDF]

				L. C. Li, J. R. Sheng, N. Mulherkar, B. S. Prabhakar, and M. N. Meriggioli Regulation of Apoptosis and Caspase-8 Expression in Neuroblastoma Cells by Isoforms of the IG20 Gene Cancer Res., September 15, 2008; 68(18): 7352 - 7361. [Abstract] [Full Text] [PDF]